Skip to main content

Table 3 Uncontrolled cohort studies reporting post-transplant outcomes of melanoma diagnosed prior to solid organ transplantation

From: Systematic review of melanoma incidence and prognosis in solid organ transplant recipients

First author (publication year)

Population based

Location

Transplant data source

Number of patients with pre-transplant melanoma

Staging data (number of patients with data)

Post-transplant outcomes (number of patients)

Chapman[30]

Yes

Australia, New Zealand

ANZDATA

19

Not available

Recurrence (2)

Brewer[20]a

No

United States

Mayo Clinic databases, OPTN, IPITTR (1967–2007), SEER

59

Breslow depth (15)

Median post-melanoma follow-up of 10.5 years:

Local recurrence (0)

Nodal metastasis (1)

      

Lung metastasis (1)

Matin[26]

No

Europe

SCOPE network (14 clinics)

9

Breslow depth (6)

No deaths after median post-melanoma follow-up of 14 years

  1. aOverlap with two prior studies[25, 28].
  2. ANZDATA, Australian and New Zealand Dialysis and Transplant Registry; IPITTR, Israel Penn International Transplant Tumor Registry; OPTN, Organ Procurement and Transplantation Network; SCOPE, Skin Care in Organ transplant Patients, Europe; SEER, Surveillance, Epidemiology and End Results.